|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A SINGLE BLIND CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF COMPOUND UNANI FORMULATION IN MANAGEMENT OF DAUS' SADAF (PSORIASIS) |
| Authors Name: | DR. SYED SOFIAN AHMED , DR. MOHAMMED AHSAN FAROQUI , DR. ABDUL LATEEF SIDDIQUI |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_214319
|
| Published Paper Id: | IJNRD2402247 |
| Published In: | Volume 9 Issue 2, February-2024 |
| DOI: | |
| Abstract: | ABSTRACT Background and Objective: Daus ’Sadaf / Taqashur-e-jild, Psoriasis is one the common diseases of the skin, It is characterized by having sharply demarcated scaly red, coin-sized skin lesions most often on the elbows, knees, scalp, hands and feet. Symptoms include itching, irritation, stinging and pain. Signs to diagnose psoriasis are Koebner phenomenon and Auspitz’s sign, there are two key factors which play a important role in Aetiology of psoriasis, 1. Autoimmune: - Naïve t cells, il12 & il23, 2. Genetic factors: - family history found Up to 30%. However, the Daus ’Sadaf commonly developed for those who has loosed their body immunity or Quath-e-Muddabir-e-Badan (Defensive Mechanism) due to abnormal maintenance of "Sitta Zarooria" many caused alternate the Tabiyath (immunity) and abnormal changes will take place in the humorous and temperament. In Unani concept their might be accumulation of abnormal Sauda and Safra Mutahirqa (Jala huwa safra) into the skin, Hence the objective of the study is to Relief nature of the disease through Unani medicine. Methods: - The study was designed as A Single Blind clinical trail with a sample size 40 patients Joshanda:-21 days Beeq-e-azkhar, Beeq-e- badiyan, Beeq-e-kibr, Beeq-e-karafs, Beeq-e-Kasni, Charaita, Shahitra, Aftimoon, Bisfaij, each 5 grams (OD Dose Before meals 21 days) • Musafiyat:-30 days 1. Qurs-e-sartaan kafoori, one tab BD (after food) 2. Arq-e-murakab musafi khoon, 60ml BD (after food) • Zimad Drugs (Local application): During whole duration of treatment. Ashaq 5 grams, Muqil-e-arzaq 5 grams, Zarvand mudharij 5 grams, Roghan-e-gul 20 ml, Moom-e-zard 20 grams Apply Zimad for a period of (51) days and response of treatment observed, First follow up after using 21 days joshanda (decoction) and then follow up for every 15 days and noted in the case sheets. Similarly, the treatment and response of the lesions measured by PASI Score and Data Analyzed statically. Result: - In this present clinical study of psoriasis, the maximum response out of (40) cases, (24) patients i.e. 60% patients got good response, the satisfactory patients were (10) i.e. 25% and poor response patients were (6) i.e. 15%. P value is <0.0001*. Interpretation and Conclusion: - The study revealed that usage of this Unani medicine got good response in decreasing the sign and symptoms of psoriasis like redness, thickness, itching, and scales. No clinically significant side effects were observed in this study; these results conclude that the drugs used in this study are easily available, safe and effective. Keywords: - Koebner phenomenon, Auspitz’s sign, Quath-e-Muddabir-e-Badan, Sitta Zarooria. |
| Keywords: | Key words:- Koebner phenomenon, Auspitz’s sign, Quath-e-Muddabir-e-Badan, Sitta Zarooria. |
| Cite Article: | "A SINGLE BLIND CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF COMPOUND UNANI FORMULATION IN MANAGEMENT OF DAUS' SADAF (PSORIASIS)", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 2, page no.c399-c417, February-2024, Available :http://www.ijnrd.org/papers/IJNRD2402247.pdf |
| Downloads: | 000118785 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2402247 Registration ID: 214319 Published In: Volume 9 Issue 2, February-2024 DOI (Digital Object Identifier): Page No: c399-c417 Country: HYDERABAD, Telangana, India Research Area: Medical Science Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2402247 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2402247 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn